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Summary 
Background: Respiratory syncytial virus (RSV) is a major cause of community acquired severe respiratory 
illness in infants, immunocompromised individuals and the elderly. Limited information exists on the 
contribution of RSV in respiratory Hospital Associated Infection (rHAI) in developing countries. 
Objective:  To characterize Respiratory Syncytial Virus in the three Kenyan referral setting as a potential 
contributor to respiratory hospital acquired infection. 
Methods: The study targeted all patients whose samples tested positive for RSV from the ongoing surveillance 
on healthcare associated respiratory infections. The study collected nasal and oropharyngeal samples from 
patients who developed new-onset axilla fever and influenza like illness, in patients who had been afebrile for 
at least three (3) days in the wards and tested them for different respiratory pathogens (Influenza A and B, 
Parainfluenza, Human metapneumovirus and adenovirus) alongside RSV. During this period A total of 37 
samples tested RSV positive. These were characterized as RSV-A and -B using RT-PCR. Those that typed 
successfully were then sequenced in the attachment G protein and phylogenetically analyzed.  
Results:  Of the 37 samples, 13(35%) were RSV A, 6 (16%) RSV B, 1 (3%) was AB and 17 (46%) did not type. 
Twenty out of the 37 attained the sequencing criteria and only seventeen gave successful sequences. Three 
RSV- A and 2 RSV-B sequenced samples from KNH were 100% identical in the G ectodomain sequences. One 
RSV-A specimen from MDH and one RSV-A positive from NNPGH had 100% identity. Three sequences from 
KNH clustered with high nucleotide sequence identity. Children below 2years were significantly more at risk of 
RSV than those aged 5years and above (aOR=0.21,p=0.012). 
Conclusions: The study inferred possibility of spread of RSV within the hospitals especially the paediatric ward. 
Any interventions to curb the spread should specifically target all children ≤ 2 years. 
[Afr J Health Sci. 2016; 29(1):1-12]  
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Introduction  
Hospital associated infections substantially contribute to 
morbidity and mortality, represent an important public 
health concern and also increases both direct and 
indirect costs of patients’ care[1].  Nosocomial 
infections are largely undocumented as a health risk in 
developing countries, but they are likely to become 
public health priorities as awareness of their occurrence 
increases [2]. Low resource setting fosters nosocomial 
spread of infection due to overcrowding, multiple bed 
occupancy as well as absence of space for cohorting 
and quarantine. 
 Viruses are important causes of lower respiratory tract 
infection [LRTI] in developing countries [3] and RSV is 
one of the most common causes of viral LRTI [4].  
Human respiratory syncytial virus [HRSV] is the leading 
cause of severe lower respiratory tract infection in 
infants and young children[5]. The virus is the most 
common cause of nosocomial infection in paediatric 
wards with up to 45% of contacts acquiring infections 
[6]. It presents with cough, rhinitis and mild fever over a 
period of four to five days. In adults it tends to cause 
mild cold symptoms, in school-aged children it causes 
a cold and bronchial cough, while in infants and 
toddlers it causes bronchiolitis or pneumonia. RSV also 
causes serious pulmonary disease and death in adults 
particularly the elderly[7] and the immunocompromised 
individuals [8]. 
 In a prospective surveillance conducted between 2002 
and 2007 in Kilifi district, Kenya, the prevalence of RSV 
was documented to be 27% with a 2.2% mortality rate, 
with more than 1000 hospitalizations per 100,000 
infants [9].  
This study sought to characterize nosocomial RSV 
transmitted within three referral hospitals by sequencing 
and to determine the age distribution of the patients 
with the virus. 
 
Methods 
Study sites and population 
This was a lab based descriptive study that was nested 
within an ongoing hospital associated infection 
surveillance study in Kenya conducted by 
KEMRI/CGHR under the Infection Control Programme 
[10].  The study used archived nasopharyngeal and 
oropharyngeal samples collected from 1st September 
2009 through 31st August 2011. [Protocal number 
2571] 
The samples were collected from Kenyatta National 
Hospital [KNH], New Nyanza provincial general 
[NNPGH] and Mbagathi District Hospital [MDH]. The 
hospitals were selected on the basis of their 
geographical and public status, i.e. district, provincial or 
referral hospital status. KNH is a referral hospital 
located in Nairobi. It has 1800 beds with 89,000 
admissions and 600,000 outpatient visits annually with 
a 7 day average length of hospital stay. It has several 
types of wards which include; medical, surgical 
paediatric wards and the special units NNPGH is a 
provincial referral hospital located in Kisumu. It is the 
largest public hospital in Nyanza province Kenya. It 
receives referrals from the western part of Kenya. It has 
300 beds, 18300 admissions and 13,306 outpatient 
visits annually.  
MDH is located in Nairobi. The hospital serves the 
general population in Nairobi and is among the largest 
TB hospital in Nairobi therefore receiving a vast number 
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of pneumonia cases; it is also classified as an infectious 
disease hospital. It has 200 beds with annual 
admissions of 12900. 
The study population consisted of all patients who had 
been admitted in the specific wards of study, the 
paediatrics wards, general wards, intensive care unit 
and the special units. 
 
Sample Size calculation 
The population of interest are the RSV positive cases 
collected between September 2009 to July 2011, these 
were 40 in number; thus a finite population. 
Thus for the sample size we used the below formula 
 
n=p*[1-p]*[Z 1-α/2]2   
                      e2 
p=0.50 
Z 1-α/2 =1.96 at α=0.05 and 95 % level of confidence 
e=0.05  
Thus giving n=384.16 
Recalling that the population of the RSV Positive cases 
has a finite number we employ a sample size 
adjustment factor, i.e. the finite population correction 
factor.  
n corrected=n * N   
                       N+n 
 
Where n is the uncorrected sample size, and N is the 
population size. 
 
In our case  
n=384.16 
 
N=40 
Hence the corrected sample size for the laboratory staff 
sample is  
n corrected=384.16 * 40   
                      40+384.16 
n corrected =36.2278 
Thus approximately the corrected sample size for the 
laboratory sample is 37 
 
Sample collection  
The study targeted all the patients whose specimen 
tested positive for RSV from the ongoing study for the 
healthcare associated infections and used archived 
samples [Protocal number 2571] where Nasal and 
oropharyngeal specimen were collected from patients 
who developed new-onset axilla fever, in patients who 
had been afebrile for at least three [3] days in the 
wards. Details of the study are described elsewhere 
[10]. Based on clinical information collected on 
suspected HAI cases, suspected HAI RSV was defined 
as a patient with new-onset fever/hypothermia with 
concurrent respiratory signs and symptoms which were 
not present at the time of admission. Since the 
incubation period for RSV is 4 to 6 days, samples from 
patients who tested positive for RSV and were in the 
ward for less than 7days were excluded from this 
analysis. 
Screening of the samples was done using real time 
Reverse Transcriptase PCR [rt-RT PCR] to identify all 
the RSV positive samples alongside other viruses[10] 
[Protocal number 2571]. Group specific PCR was 
carried out to classify the RSV positive samples into 
groups A and B [11]  
Extracted viral RNAs were reverse transcribed and 
amplified in a one-step reaction protocol [QIAGEN, Ltd] 
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with primers targeting the RSV G gene [AG20 and 
F164][12]. For the second round PCR A microlitre of 
the resultant products was further amplified in nested 
PCR procedure with the primers BG10 and F1, as 
previously described [12]. 
The product was visualized by ethidium bromide 
staining gel electrophoresis on a 2% agarose gel to 
confirm the success of amplification and the G gene 
PCR product was purified using GFX purification kit 
[GE, Healthcare, UK Limited ]. 
Four primers [5pmol/ul] were used in the RSV G-gene 
BigDye sequencing reaction on a 3130xl sequencher 
[Applied Biosystems]. Contig assembly was done in 
sequencher 5.10 [Gene codes corporation, USA ] [12] 
and the sequence alignments were done in BioEdit. 
Phylogenetic trees were generated in MEGA 5 program 
[13] and trees constructed using maximum likelihood 
method. The appropriate model of evolution was 
determined in jmodeltest. Sequences from GenBank 
representative of all known RSV genotypes were 
included in the alignments to genotype the strains we 
identified. The robustness of the tree branching patterns 
was evaluated by bootstrapping with 1000 iterations. 
The trees were drawn to scale with 0.01 nucleotide 
substitution. 
 
Data Analysis 
Data was analyzed using STATA [version 11; Stata 
Corporation, College Station, TX]. Descriptive Statistics 
was used to describe distribution of patients by their 
demographic characteristics, by gender of the patients, 
the hospitals to which they were admitted, age 
distribution [which was categorized into those under 2 
years, between 2 to 5 years and those above 5 years] 
and also distribution by ward type. The wards included 
the paediatrics unit, intensive care unit, burns unit, 
surgical wards and the medical ward.  
 
Ethical Clearance 
This study was approved by the KEMRI Scientific 
Steering Committee and the KEMRI National Ethical 
Review Committee [protocol SSC No. 2571]. Consent 
to store aliquots of the samples for further analysis was 
sought from the participants prior to sample collection 
and the minors were assented for according to the 
World Health Organization guidelines. 
 
Results 
Demographics and clinical characteristics 
From September 2009 to August 2011 a total of 37 
patient specimens [15%] tested positive for RSV by 
routine real time PCR viral screening. Of these, 
13[35%] were RSV A, 6 [16%] RSV B, 1 [3%] AB and 
17[46%] did not type. Of the twenty [54%] samples that 
were sequenced, 17 [85%] were successfully 
sequenced [9 KNH, 4 MDH and 4 NNPGH].  
Of the sequenced specimen, 56% were from males with 
majority of the patients [50%] being from Kenyatta 
National Hospital. Children below 2years were 
significantly more at risk of RSV than those aged 
5years and above [aOR=0.21,p=0.012]. There was no 
statistically significant difference in the risk for children 
2-4yrs compared to children below 2years 
[aOR=0.85,p=0.7342]. 
Phylogenetic analysis  
Phylogenetic tree analysis of the RSV A sequences 
[figure 1] showed that all the samples collected from the 
hospitals were genetically similar and clustered together 
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as one clade. Three RSV group A sequenced samples 
from KNH [39/09, 40/09 and 41/09] were identical in 
the G ectodomain sequences with 63% bootstrap value 
and near 100% nucleotide similarity. Two samples, both 
RSV-A specimens [MDH, 023/2010, [NNPGH, 
021/2010], were over 90% identical although these 
hospitals are approximately 160 miles apart. All the 
sequences in group B belonged to one genotype, the 
BA1 genotype, but they were in 3 different clusters 
which were not hospital specific. The sequences had 
genetic differences within the clusters but two samples 
from KNH [176 and 177] had almost 100% nucleotide 
similarity with a boot strap value of over 90%. The 
sequences collected from the three referral hospitals 
were observed to be closely related despite their 
distances apart.  
Figure 1: Phylogenetic trees  
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Figure 1: Phylogenetic analysis of RSV-A depicting 
virus genotypes identified during the study period. 
Closed circle show viruses detected from Kenyatta 
National Hospital, closed rectangle are samples from 
New Nyanza Provincial Hospital and closed triangle 
from Mbagathi District Hospital. The sample naming 
includes sample name-month of collection-year of 
collection.  
For the RSV B group, two samples, HAI KNH 176 and 
177 had the same genotype with the same date of virus 
detection. The two patients had different length of 
hospital stay but they had both stayed in hospital for 
more than two months. It was also observed that all the 
patients except one HAINNPGH 019 had been in 
hospital more than two weeks before showing 
symptoms of RSV [Table 2 showing length of hospital 
stay before onset of RSV]  
 
Figure 2: RSV-B phyl
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Figure 2: RSV-B phyl. RSV-B phylogenetics showing genotypic relationship of viruses identified between the years 
2009-2011. Closed circle show viruses detected from Kenyatta National Hospital, closed rectangle are samples from 
New Nyanza Provincial Hospital and closed triangle from Mbagathi District Hospital. The sample naming includes 
sample name-month of collection-year of collection.  
 
Figure 3: Patient time of admission 
.  
Figure 3: Graph showing patient time of admission, date RSV A virus was detected and the outcome date. 
 
Key -- Duration of hospital stay before virus was detected 
 ― Duration of hospital stay after virus detection 
 * Date of virus detection 
 • Date of outcome 
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Table 1a: Demographic characteristics of all RSV positive samples 
 
 
Table 1b: Demographic characteristics and RSV samples that were sequenced 
Group Characteristic  [N*=16] n [%] 
Gender Female  
Male 
7 [43.8] 
9 [56.2] 
Hospital KNH 
MDH 
NNPGH 
8 [50.0] 
4 [25.0] 
4 [25.0] 
Age Categories <2 Years  
2 to <5 Years 
5 Years and above 
12 [75.0] 
4 [25.0] 
0 [0.0] 
Characteristics  Subtypes 
 RSV positives [n=37] A [n=13] B [n=6] AB [n=1] Non-Subtyped [n=17] 
Gender      
Male 
Female 
22 [59.5] 
15 [40.5] 
8 [61.5] 
5 [38.5] 
3 [50.0] 
3 [50.0] 
1 [100.0] 
0 [0.0] 
10 [58.8] 
7 [41.2] 
Age Group       
Adult 
Child 
5 [13.5] 
32 [86.5] 
0 [0.0] 
13 [100.0] 
0 [0.0] 
6 [100.0] 
0 [0.0] 
1 [100.0] 
5 [29.4] 
12 [70.6] 
Hospital      
KNH 
MDH 
NNPGH 
22 [59.5] 
9 [24.3] 
6 [16.2] 
7 [53.8] 
3 [23.1] 
3 [23.1] 
4 [66.7] 
1 [16.7] 
1 [16.7] 
1 [100.0] 
0 [0.0] 
0 [0.0] 
10 [58.8] 
5 [29.4] 
2 [11.8] 
Ward Type      
Burns Unit 
ICU 
Medical 
Paediatrics 
Special 
Surgical 
1 [2.7] 
4 [10.8] 
1 [2.7] 
30 [81.1] 
1 [2.7] 
0 [0.0] 
1 [7.7] 
0 [0.0] 
0 [0.0] 
12 [92.3] 
0 [0.0] 
0 [0.0] 
0 [0.0] 
0 [0.0] 
0 [0.0] 
6 [100.0] 
0 [0.0] 
0 [0.0] 
0 [0.0] 
0 [0.0] 
0 [0.0] 
1 [100.0] 
0 [0.0] 
0 [0.0] 
0 [0.0] 
4 [23.5] 
1 [5.9] 
11 [64.7] 
1 [5.9] 
0 [0.0] 
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Table 2: Multivariate analysis of demographic characteristics in relation to RSV positivity 
  RSV Positivity Adjusted 
Characteristic n/N [% Positive] Adjusted Odds Ratio [OR] p-value 
Age      
<2 Years 24/85 [28.2 %] Reference   
2-4 Years  7/36 [19.4 %] 0.85[0.33-2.17] 0.7342 
5+years  6/127 [4.7 %] 0.21[0.06-0.71] 0.0117 
Ward Type      
Paediatrics    1/5 [20.0 %] Reference  
ICU    4/59 [6.8 %] 0.63[0.17-2.39] 0.5002 
Others    1/30 [3.3 %] 0.37[0.09-1.46] 0.1546 
 
DISCUSSION 
This study describes a retrospective investigation on 
respiratory samples collected from patients admitted to 
three referral hospitals in Kenya and were subsequently 
infected with RSV during their hospital stay. The study 
identified both group A and B genotypes were 
circulating in the three hospitals with limited diversity 
within the groups 
Several studies have been documented to have shown 
yearly shifts in relative predominance between group A 
and B strains [14, 15]; However, in our study an 
epidemiologic pattern and any immunologic and clinical 
implications may be difficult to detect as the isolates 
examined in any one site were generally few in number 
and were mainly from hospitalized individuals. Never 
the less there was a clear group shift infered in this 
study with group A predominating in 2009 to early 2010 
and group B predominating in late 2010-2011. This 
mirrors Peret et al’s observation, that there is no 
genotype or subtype that predominates for more than 
one season and hypothesized that this drives changes 
in protective immunity in the population [15]. A lack of 
protective immunity in the community enables the virus 
to transmit more effectively. Identifying differences 
between strains within groups was achieved by 
phylogenetic analysis and all sequences in the different 
groups were observed to be genetically related. 
Isolation of viruses with identical sequences indicates a 
common source [15] .There were slight genetic 
differences within the clades but three group A 
sequences from Kenyatta National Hospital, KNH 039, 
KNH 040 and KNH 041 [Gene Bank accession 
numbers KJ556906, KJ556907 and KJ556908] and 
two group B sequences from the same hospital, KNH 
176 and KNH 177[Gene Bank accession numbers 
KJ556913 AND KJ556914] were above 90% identical. 
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This infers a possibility of a common source of infection 
within the hospital.  
Incomplete immunity to RSV results in repeated 
infections throughout life, this together with the fact that 
shedding of the virus in the respiratory secretions of 
young children tends to be for long periods and at high 
titer [14] facilitates it’s nosocomial spread.  
Patients in the paediatric wards require frequent hands 
on care which is provided by multiple healthcare 
providers and guardians therefore increasing their 
potential to community pathogens [16] . Most 
developing countries face challenges in controlling HAIs 
due to their congested nature. This may be the 
consequence of inadequate ventilation in the wards, 
sharing of facilities like beds in general wards and there 
is also likelihood of sharing equipment like ventilators in 
the facilities. Infection control measures might be hard 
to be adhered to due to inadequate staffing, of infection 
control personnel and lack of adequate infection control 
supplies,  
The Centers for Disease Control [CDC] and WHO 
recommends frequent hand washing with soap and 
water, cleaning contaminated surfaces with disinfectants 
and reduced interaction between individuals with flu like 
symptoms with high risk children. As much as possible, 
limit the time high risk children spend in child-care 
centers or other contagious centers. The findings of this 
study suggest that there is a likelihood of nosocomial 
spread of RSV within the three hospitals. However, 
finding of the similar sequence between patients does 
not give the conclusion that there is nosocomial 
transmission therefore additional study on full length 
genome sequencing should be done. This will explain if 
there are changes elsewhere in the genome of the 
isolates.  
Education on the transmission and control measures 
needs to be emphasized among the health care 
providers in order to intervene in the nosocomial spread 
of RSV. This can be achieved by most importantly 
creating awareness of RSV characteristic and its nature 
of infection. Introducing education programs in the 
hospitals is an important key in infection control and this 
can be done through regular continuous medical 
education for the medical staff. Strict infection control 
measures should be put in place, planning and 
implementing feasible and effective control measures 
has been documented to be an important step in 
controlling nosocomial RSV [14] and other respiratory 
infections. These measures include; Hand washing, use 
of proper protective equipment and infected patient 
isolation. Any interventions to curb the spread should 
majorly target children under 2 years of age. 
The main limitation in this study was the fact that it was 
not possible to determine source of HA-RSV [health 
care worker, other patient, or visitor]. Having 
temperature of more than 38 oC as a major criteria of 
inclusion to the study could have possibly limited the 
chances of capturing asymptomatic cases of RSV, since 
RSV does not necessarily present with fever. 
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